Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Christopoulos

Showing results (81-90 of 331) with videos related to

Pageof 34
Sort By:
Molecular Pharmacology|February 9, 2011
The role of transmembrane domain 3 in the actions of orthosteric, allosteric, and atypical agonists of the M4 muscarinic acetylcholine receptorKatie Leach, Anna E Davey, Christian C Felder, et al.
Drug Discovery Today|January 20, 2009
Modulating receptor function through RAMPs: can they represent drug targets in themselves?Patrick M Sexton, David R Poyner, John Simms, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 3, 2004
Evidence for pleiotropic signaling at the mouse beta3-adrenoceptor revealed by SR59230A [3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate]Dana S Hutchinson, Masaaki Sato, Bronwyn A Evans, et al.
Molecular Pharmacology|February 5, 2005
Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexesDebbie L Hay, George Christopoulos, Arthur Christopoulos, et al.
Molecular Pharmacology|May 9, 2014
Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sitesDouglas A Schober, Carrie H Croy, Hongling Xiao, et al.
Molecular Pharmacology|June 6, 2015
Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid ReceptorElham Khajehali, Daniel T Malone, Michelle Glass, et al.
Medicinal Research Reviews|May 7, 2014
Biased agonism at G protein-coupled receptors: the promise and the challenges--a medicinal chemistry perspectiveJeremy Shonberg, Laura Lopez, Peter J Scammells, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 30, 2015
Differential impact of amino acid substitutions on critical residues of the human glucagon-like peptide-1 receptor involved in peptide activity and small-molecule allosteryCassandra Koole, Denise Wootten, John Simms, et al.
Biotechniques|April 16, 2013
A simple method to generate stable cell lines for the analysis of transient protein-protein interactionsEmilia Elizabeth Savage, Denise Wootten, Arthur Christopoulos, et al.
The Journal of Biological Chemistry|January 7, 2010
Identification of orthosteric and allosteric site mutations in M2 muscarinic acetylcholine receptors that contribute to ligand-selective signaling biasKaren J Gregory, Nathan E Hall, Andrew B Tobin, et al.
Pageof 34

Showing results (81-90 of 331) with videos related to

Sort By:
Pageof 34
Molecular Pharmacology|February 9, 2011
The role of transmembrane domain 3 in the actions of orthosteric, allosteric, and atypical agonists of the M4 muscarinic acetylcholine receptorKatie Leach, Anna E Davey, Christian C Felder, et al.
Drug Discovery Today|January 20, 2009
Modulating receptor function through RAMPs: can they represent drug targets in themselves?Patrick M Sexton, David R Poyner, John Simms, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 3, 2004
Evidence for pleiotropic signaling at the mouse beta3-adrenoceptor revealed by SR59230A [3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate]Dana S Hutchinson, Masaaki Sato, Bronwyn A Evans, et al.
Molecular Pharmacology|February 5, 2005
Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexesDebbie L Hay, George Christopoulos, Arthur Christopoulos, et al.
Molecular Pharmacology|May 9, 2014
Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sitesDouglas A Schober, Carrie H Croy, Hongling Xiao, et al.
Molecular Pharmacology|June 6, 2015
Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid ReceptorElham Khajehali, Daniel T Malone, Michelle Glass, et al.
Medicinal Research Reviews|May 7, 2014
Biased agonism at G protein-coupled receptors: the promise and the challenges--a medicinal chemistry perspectiveJeremy Shonberg, Laura Lopez, Peter J Scammells, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 30, 2015
Differential impact of amino acid substitutions on critical residues of the human glucagon-like peptide-1 receptor involved in peptide activity and small-molecule allosteryCassandra Koole, Denise Wootten, John Simms, et al.
Biotechniques|April 16, 2013
A simple method to generate stable cell lines for the analysis of transient protein-protein interactionsEmilia Elizabeth Savage, Denise Wootten, Arthur Christopoulos, et al.
The Journal of Biological Chemistry|January 7, 2010
Identification of orthosteric and allosteric site mutations in M2 muscarinic acetylcholine receptors that contribute to ligand-selective signaling biasKaren J Gregory, Nathan E Hall, Andrew B Tobin, et al.
Pageof 34